

Author: Aguiar Aderbal
Publisher: Springer Publishing Company
ISSN: 1029-8428
Source: Neurotoxicity Research, Vol.24, Iss.2, 2013-08, pp. : 280-287
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The loss of nigral dopaminergic neurons in Parkinson's disease (PD) is believed to result from interactions between genetic susceptibility and environmental factors. Although loss-of-function mutations in the parkin gene cause early-onset familial PD, the hybrid 129Sv-C57BL/6 parkin-deficient mice did not display spontaneous degeneration of the nigrostriatal pathway or enhanced vulnerability to neurotoxicity induced by 6-hydroxydopamine (6-OHDA) or intraperitoneal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication. We aimed to re-evaluate the role of parkin in a pure C57BL/6 background after an acute intranasal (i.n.) MPTP administration, a new route of toxin delivery to the brain that mimics environmental exposure to neurotoxins. We found that the deficiency of parkin gene modifies the d-amphetamine-induced locomotion in saline-treated animals. Intranasal MPTP induced Parkinsonism in parkin+/+ mice, through depletion of striatal dopamine, decreased number of dopaminergic neurons in the substantia nigra, and decreased d-amphetamine-induced hyperlocomotion. Additionally, the deletion of the parkin gene in a pure C57BL/6 background did not lead to increased vulnerability to i.n. MPTP-induced neurotoxicity. Moreover, the i.n. MPTP induced nigral astrogliosis predominantly in the pars reticulata in wild type and parkin−/− mice. Taken together, these results showed that the absence of parkin did not modify the vulnerability of nigrostriatal dopaminergic pathway after i.n. MPTP intoxication, suggesting that independently of mouse strain, the endogenous parkin is not required for protection of this system. These findings also suggest that the development of familial parkin-linked PD is not associated with exposure to environmental factors that specifically affects the dopaminergic system.
Related content




By Jackson M. Swart T. Pearce R. Jenner P.
Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. :




By Lorenzl Stefan Calingasan Noel Yang Lichuan Albers David S. Shugama Shuei Gregorio Jason Krell H. W. Chirichigno Jason Joh Tong Beal M. Flint
NeuroMolecular Medicine, Vol. 5, Iss. 2, 2004-04 ,pp. :


By Tillerson J.L. Caudle W.M. Reverón M.E. Miller G.W.
Experimental Neurology, Vol. 178, Iss. 1, 2002-11 ,pp. :